Evidence map›Paper›PMID 39613332›Full record

ArticleTobacco control2026

Marketing strategies in business-to-business advertisements for oral nicotine products.

Akshika Sharma, Amy Belton, Jenny E Ozga, Pamela Ling, Mary Hrywna, Jennifer Cornacchione Ross, Ollie Ganz, Krysten W Bold, Cassandra Stanton

Abstract read
In one paragraph

Article in Tobacco control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Akshika SharmaPsychiatry, Yale School of Medicine, New Haven, Connecticut, USA akshika.sharma@Yale.edu.ORCID 0000-0003-0651-171X
Amy BeltonUS Food and Drug Administration, Silver Spring, Maryland, USA.
Jenny E OzgaBehavioral Health and Health Policy Practice, Westat Inc, Rockville, Maryland, USA.ORCID 0000-0003-2543-561X
Pamela LingMedicine, University of California San Francisco School of Medicine, San Francisco, California, USA.ORCID 0000-0001-6166-9347
Mary HrywnaRutgers Center for Tobacco Studies, New Brunswick, New Jersey, USA.
Jennifer Cornacchione RossDepartment of Health Law, Policy and Management, Boston University School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0001-5173-3130
Ollie GanzRutgers Institute for Nicotine & Tobacco Studies, New Brunswick, New Jersey, USA.
Krysten W BoldPsychiatry, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-8012-6118
Cassandra StantonBehavioral Health and Health Policy Practice, Westat Inc, Rockville, Maryland, USA.ORCID 0000-0001-5329-6261

Funding

Yale Center for the Study of Tobacco Product Use and Addiction (YCSTP) Project 2: Addictive Threshold of Nicotine and the Impact of SweetenersU54DA036151 · NIDA · YALE UNIVERSITY · PI LISA M FUCITO · 2018 to 2026
$41.6M
Leadership and Logistics CoreU54DA046060 · NIDA · WESTAT, INC. · PI Andrea M Stroup · 2018 to 2026
$28.1M
PROJECT 5: IMPACT OF CHANGING TOBACCO PRODUCT USE ON HEALTHCARE COSTS FOR GENERAL AND VULNERABLE POPULATIONSU54HL147127 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LING, PAMELA MAY · 2018 to 2022
$20.4M
Tobacco Industry Marketing CoreU54CA229973 · NCI · UNIVERSITY OF PENNSYLVANIA · PI WACKOWSKI, OLIVIA · 2018 to 2022
$18.8M
Evaluating the potential impact of a menthol ban in cigarettes and e-cigarettes among current menthol smokersR01DA054993 · NIDA · YALE UNIVERSITY · PI BOLD, KRYSTEN W. · 2022 to 2025
$2.4M
NCI NIH HHS U54 CA229973NHLBI NIH HHS U54 HL147127NIDA NIH HHS R01 DA054993NIDA NIH HHS U54 DA036151NIDA NIH HHS U54 DA046060
6 · The paper itself

Abstract

introductionAlthough the popularity of oral nicotine products (ONPs) such as ZYN and On! is growing globally, there is limited research on their marketing and advertising. This report describes recent ONP marketing communication to retailers. Promotion to retailers can provide insight into new product flavours and styles, as well as future marketing strategies targeting consumers.

methodsWe obtained all unique ONP print and online advertisements (ads) (N=50) targeted towards US businesses between January 2016 and August 2022 from Vivvix (formerly Numerator Ad Intel). Two independent reviewers coded for type of ONP, brand, nicotine strength(s), flavour(s), slogan(s), claim(s) and frequency of each component.

resultsMost ads featured nicotine pouches alone (52%), while 22% featured a mix of ONPs including pouches, tablets and lozenges. By brand, Rogue constituted 36% of ads, followed by Zyn and On! (16% each). Most (82%) ads featured at least one cooling flavour and 48% displayed at least one fruit flavour. Wintergreen flavour appeared most frequently (48%). Most (72%) ads contained a slogan, which frequently highlighted convenience of use (eg, '

conclusionThis analysis provides insight into tobacco companies' strategies for increasing ONP endorsement among retailers. Strategies include appealing to profitability, emphasising convenience of product use and primarily promoting non-tobacco flavours. These findings highlight new trends in ONP products and marketing tactics and identify important areas to monitor to inform tobacco marketing regulations.

Indexed as

AdvertisingCommerceMarketingNicotineTobacco ProductsFlavoring AgentsHumansUnited StatesFlavoring AgentsNicotineAdvertising and PromotionHarm ReductionNicotine

Identifiers

PMID39613332
PMCPMC12116845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.